Since scores for fibrosis may not be reliable in hospitalized patients with COVID-19, which is frequently accompanied by elevated aminotransferases, and elastography was not available at the COVID-19 department, we could not evaluate the fibrosis stage; consequently, the effect of advanced NAFLD on TGF-β1 levels could not be analyzed. The gene discussed is TGFB1; the disease is metabolic dysfunction-associated steatotic liver disease.